Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07028554

Post-Market Clinical Follow-Up Study Plan for Cartridges of Disposable Endoscopic Linear Cutting Staplers

Status
Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Suzhou Care-Real Medical Technology Co., Ltd. · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Cartridges of Disposable Endoscopic Linear Cutting Staplers, Disposable Powered Endoscopic Linear Cutting Staplers and Disposable Endoscopic Linear Cutting Staplers manufactured by Ningbo Verykind Medical Device Co., Ltd. have marketed in many countries or area for many years. The investigational devices are intended for transection, resection, and/or creation of anastomoses. The instruments have application in multiple open or minimally invasive general, gynecologic, urologic and thoracic surgical procedures. In order to confirm the safety and performance of the products, as well as the continued safety and clinical performance of the implant (the staple) during the clinical follow-up period, monitor the identified side-effects, contraindications and identify previously unknown side-effects, and ensure the continued acceptability of the benefit-risk ratio, Investigators proactively collect and evaluate clinical data from different regions, including of Italy, Brazil and Chile, where the device has been marketed, and conduct PMCF studies.

Conditions

Interventions

TypeNameDescription
DEVICECartridges of Disposable Endoscopic Linear Cutting Staplers, Disposable PoweredInvestigational devices encompassing all models of the Cartridges for Disposable Endoscopic Linear Cutting Staplers, as well as Staplers utilized in conjunction with the Cartridges specified in the Study Plan (Plan number: WEKD-QS-PMCF).

Timeline

Start date
2025-01-10
Primary completion
2025-07-15
Completion
2025-07-15
First posted
2025-06-19
Last updated
2025-06-19

Locations

1 site across 1 country: Chile

Source: ClinicalTrials.gov record NCT07028554. Inclusion in this directory is not an endorsement.